EE04040B1 - Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks - Google Patents

Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks

Info

Publication number: EE04040B1
Authority: EE; Estonia
Prior art keywords: treatment; cardiovascular diseases; aminotetraline; derivative; aminotetraline derivative
Prior art date: 1995-03-17

Application number

EE9700231A

Other languages

English (en)

Other versions

EE9700231A (et

Inventor

Chiesi Paolo

Bongrani Stefano

Razzetti Roberta

Civelli Maurizio

Umile Alberto

Original Assignee

Chiesi Farmaceutici S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-17

Filing date

1996-03-13

Publication date

2003-06-16

1996-03-13 Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.

1998-04-15 Publication of EE9700231A publication Critical patent/EE9700231A/et

2003-06-16 Publication of EE04040B1 publication Critical patent/EE04040B1/et

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Cardiology (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

EE9700231A 1995-03-17 1996-03-13 Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks EE04040B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT95MI000532A IT1275935B1 (it)	1995-03-17	1995-03-17	Derivato di aminotetralina per la terapia di malattie cardiovascolari
PCT/EP1996/001060 WO1996029065A2 (en)	1995-03-17	1996-03-13	Aminotetralin derivative for the therapy of cardiovascular diseases

Publications (2)

Publication Number	Publication Date
EE9700231A EE9700231A (et)	1998-04-15
EE04040B1 true EE04040B1 (et)	2003-06-16

Family

ID=11370947

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9700231A EE04040B1 (et)	1995-03-17	1996-03-13	Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks

Country Status (31)

Country	Link
US (2)	US6013678A (et)
EP (2)	EP0814791B1 (et)
JP (1)	JPH11502211A (et)
KR (1)	KR100391143B1 (et)
CN (1)	CN1112920C (et)
AT (1)	ATE218856T1 (et)
AU (1)	AU702656B2 (et)
BR (1)	BR9607996A (et)
CA (1)	CA2215671A1 (et)
CZ (1)	CZ288488B6 (et)
DE (1)	DE69621786T2 (et)
DK (1)	DK0814791T3 (et)
EA (1)	EA000937B1 (et)
EE (1)	EE04040B1 (et)
ES (1)	ES2177769T3 (et)
HK (2)	HK1004802A1 (et)
HU (1)	HUP9801686A3 (et)
IL (1)	IL117518A (et)
IT (1)	IT1275935B1 (et)
LT (1)	LT4355B (et)
LV (1)	LV11882B (et)
MX (1)	MX9706971A (et)
NO (1)	NO317402B1 (et)
NZ (1)	NZ303993A (et)
PL (1)	PL183347B1 (et)
PT (1)	PT814791E (et)
SI (1)	SI9620036B (et)
SK (1)	SK282952B6 (et)
TR (1)	TR199700963T1 (et)
WO (1)	WO1996029065A2 (et)
ZA (1)	ZA962073B (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2695157B2 (ja) *	1986-12-29	1997-12-24	松下電器産業株式会社	可変パイプラインプロセッサ
WO2000076544A1 (en) *	1996-03-13	2000-12-21	Chiesi Farmaceutici S.P.A.	Aminotetralin derivative for the therapy of cardiovascular diseases
EP1331004A3 (en) *	1999-06-09	2003-08-06	CHIESI FARMACEUTICI S.p.A.	Aminotetralin Derivative for the Therapy of Cardiovascular Diseases
AU766230B2 (en) *	1999-06-09	2003-10-09	Chiesi Farmaceutici S.P.A.	Aminotetralin derivative for the therapy of cardiovascular diseases
IT1313583B1 (it) *	1999-07-30	2002-09-09	Chiesi Farma Spa	Derivati 2-amminotetralinici per la terapia del glaucoma.
IL152751A0 (en) *	2000-05-12	2003-06-24	Chiesi Farma Spa	Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
SE0101854L (sv) *	2001-05-28	2002-11-29	Bioneris Ab	Användning av en förening med en negativt laddad region av grupper för behandling av restenos.
EP1384708A1 (en) *	2002-07-26	2004-01-28	CHIESI FARMACEUTICI S.p.A.	Process for the manufacture of form I of nolomirole hydrochloride
US20050101668A1 (en) *	2003-07-24	2005-05-12	Chiesi Farmaceutici S.P.A.	Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4134997A (en) *	1977-03-01	1979-01-16	University Of Iowa Research Foundation	Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts
SU998342A1 (ru)	1981-12-11	1983-02-23	Предприятие П/Я А-3732	Способ получени синтетического цеолита типа @
IT1218322B (it) *	1982-06-10	1990-04-12	Chiesi Farma Spa	Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche

1995
- 1995-03-17 IT IT95MI000532A patent/IT1275935B1/it active IP Right Grant
1996
- 1996-03-13 JP JP8528045A patent/JPH11502211A/ja not_active Ceased
- 1996-03-13 WO PCT/EP1996/001060 patent/WO1996029065A2/en not_active Application Discontinuation
- 1996-03-13 NZ NZ303993A patent/NZ303993A/xx unknown
- 1996-03-13 HU HU9801686A patent/HUP9801686A3/hu unknown
- 1996-03-13 BR BR9607996A patent/BR9607996A/pt not_active Application Discontinuation
- 1996-03-13 TR TR97/00963T patent/TR199700963T1/xx unknown
- 1996-03-13 EP EP96907446A patent/EP0814791B1/en not_active Expired - Lifetime
- 1996-03-13 CA CA002215671A patent/CA2215671A1/en not_active Abandoned
- 1996-03-13 PT PT96907446T patent/PT814791E/pt unknown
- 1996-03-13 CZ CZ19972866A patent/CZ288488B6/cs not_active IP Right Cessation
- 1996-03-13 EP EP02001772A patent/EP1216702A3/en not_active Withdrawn
- 1996-03-13 AU AU51072/96A patent/AU702656B2/en not_active Ceased
- 1996-03-13 DE DE69621786T patent/DE69621786T2/de not_active Expired - Fee Related
- 1996-03-13 SI SI9620036A patent/SI9620036B/sl not_active IP Right Cessation
- 1996-03-13 AT AT96907446T patent/ATE218856T1/de not_active IP Right Cessation
- 1996-03-13 MX MX9706971A patent/MX9706971A/es not_active IP Right Cessation
- 1996-03-13 ES ES96907446T patent/ES2177769T3/es not_active Expired - Lifetime
- 1996-03-13 EA EA199700243A patent/EA000937B1/ru not_active IP Right Cessation
- 1996-03-13 US US08/913,363 patent/US6013678A/en not_active Expired - Fee Related
- 1996-03-13 KR KR1019970706438A patent/KR100391143B1/ko not_active IP Right Cessation
- 1996-03-13 CN CN96193312A patent/CN1112920C/zh not_active Expired - Fee Related
- 1996-03-13 EE EE9700231A patent/EE04040B1/et not_active IP Right Cessation
- 1996-03-13 SK SK1254-97A patent/SK282952B6/sk unknown
- 1996-03-13 PL PL96322284A patent/PL183347B1/pl not_active IP Right Cessation
- 1996-03-13 DK DK96907446T patent/DK0814791T3/da active
- 1996-03-14 ZA ZA962073A patent/ZA962073B/xx unknown
- 1996-03-17 IL IL11751896A patent/IL117518A/en not_active IP Right Cessation
1997
- 1997-09-15 LV LVP-97-166A patent/LV11882B/en unknown
- 1997-09-15 LT LT97-147A patent/LT4355B/lt not_active IP Right Cessation
- 1997-09-16 NO NO19974267A patent/NO317402B1/no not_active IP Right Cessation
1998
- 1998-05-12 HK HK98104093A patent/HK1004802A1/xx not_active IP Right Cessation
1999
- 1999-06-09 US US09/328,434 patent/US6103760A/en not_active Expired - Fee Related
2002
- 2002-12-19 HK HK02109206.9A patent/HK1048060A1/zh unknown

Also Published As

Publication number	Publication date
JPH11502211A (ja)	1999-02-23
AU5107296A (en)	1996-10-08
PT814791E (pt)	2002-10-31
LV11882B (en)	1998-03-20
DK0814791T3 (da)	2002-10-07
SK125497A3 (en)	1998-02-04
MX9706971A (es)	1997-11-29
HUP9801686A2 (hu)	1999-06-28
SI9620036A (sl)	1998-02-28
EE9700231A (et)	1998-04-15
PL183347B1 (pl)	2002-06-28
NO317402B1 (no)	2004-10-25
KR100391143B1 (ko)	2003-11-28
IT1275935B1 (it)	1997-10-24
CZ286697A3 (cs)	1998-03-18
CN1181699A (zh)	1998-05-13
LT4355B (lt)	1998-06-25
HK1004802A1 (en)	1998-12-11
ES2177769T3 (es)	2002-12-16
CN1112920C (zh)	2003-07-02
AU702656B2 (en)	1999-02-25
NZ303993A (en)	2000-12-22
US6103760A (en)	2000-08-15
HK1048060A1 (zh)	2003-03-21
LT97147A (en)	1998-02-25
EP0814791B1 (en)	2002-06-12
EP1216702A2 (en)	2002-06-26
EP0814791A1 (en)	1998-01-07
TR199700963T1 (xx)	1998-02-21
EP1216702A3 (en)	2002-09-04
ATE218856T1 (de)	2002-06-15
CZ288488B6 (en)	2001-06-13
ZA962073B (en)	1996-11-27
NO974267L (no)	1997-11-07
LV11882A (lv)	1997-12-20
ITMI950532A1 (it)	1996-09-17
US6013678A (en)	2000-01-11
ITMI950532A0 (it)	1995-03-17
SI9620036B (sl)	2002-10-31
HUP9801686A3 (en)	1999-10-28
WO1996029065A2 (en)	1996-09-26
SK282952B6 (sk)	2003-01-09
EA199700243A1 (ru)	1998-02-26
CA2215671A1 (en)	1996-09-26
NO974267D0 (no)	1997-09-16
EA000937B1 (ru)	2000-06-26
WO1996029065A3 (en)	1996-11-28
KR19980703030A (ko)	1998-09-05
BR9607996A (pt)	1998-06-23
DE69621786D1 (de)	2002-07-18
IL117518A0 (en)	1996-07-23
IL117518A (en)	2001-05-20
PL322284A1 (en)	1998-01-19
DE69621786T2 (de)	2003-01-02

Legal Events

Date	Code	Title	Description
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2005-12-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20050313

Publication	Publication Date	Title
BR9714363A (pt)	2000-03-21	Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
KR960702318A (ko)	1996-04-27	근육 질병 및 장애의 치료방법
HUP9900773A3 (en)	2000-04-28	Use of carbazole derivatives for producing pharmaceutical compositions suitable for the treatment of congestive heart failure
NO20075065L (no)	1999-02-25	Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
ITTO950104A0 (it)	1995-02-15	Catetere, particolarmente per il trattamento di aritmie cardiache.
IE791235L (en)	1979-12-27	Acyl-derivatives of carnitine.
ATE239474T1 (de)	2003-05-15	Verwendung von levobupivacain
EE04040B1 (et)	2003-06-16	Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks
ITTO950099A0 (it)	1995-02-14	Catetere, particolarmente per il trattamento di aritmie cardiache.
ATE157871T1 (de)	1997-09-15	Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind
ATE151774T1 (de)	1997-05-15	Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DE69018099T2 (de)	1995-08-03	Polyamin-Derivate als antineoplastische Mittel.
EP0576913A3 (en)	1995-04-19	Digitoxigenin and dihydrodigitoxigenin 3-beta derivatives and pharmaceutical preparations thereof, for the treatment of cardiovascular diseases.
GR3029466T3 (en)	1999-05-28	1,5-disubstituted 7a-methylperhydroinden-3a-ol derivatives, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
ATE236159T1 (de)	2003-04-15	Neuartige bispidin-derivate, die sich zur behandlung von herzrhythmusstörungen eignen
ITMI950956A0 (it)	1995-05-12	Uso degli enantiomeri (s) di derivati 1,4-diidropiridinici per il trattamento dell'insufficienza cardiaca
IT8421753A0 (it)	1984-07-04	Agenti terapeutici per il trattamento di disturbi cardiaci edella circolazione, delle dislipidemie e delle deficienze delle prestazioni muscolari, procedimento per la loro preparazione e relative composizioni farmaceutiche.